Skip to main content
. 2023 Sep 20;16(12):2712–2720. doi: 10.1093/ckj/sfad238

Table 4:

Subgroup analysis of the primary composite outcome (MACE and all-cause mortality) and the secondary outcome (all-cause mortality).

Primary composite outcome
(MACE + all-cause mortality)
Secondary outcome
(all-cause mortality)
Subgroup N HR (95% CI) P-value HR (95% CI) P-value
Sex
 Male 560 1.23 (0.84; 1.82) .29 1.36 (0.81; 2.28) .24
 Female 336 1.26 (0.80; 2.00) .31 1.78 (0.94; 3.37) .08
Age
 <60 years 428 1.49 (0.90; 2.47) .12 1.92 (0.86; 4.26) .11
 60–70 years 270 1.25 (0.72; 2.16) .42 1.69 (0.83; 3.43) .15
 >70 years 198 1.16 (0.69; 1.96) .57 1.31 (0.71; 2.45) .39
CKD stage
 0–1 234 0.75 (0.26; 2.13) .36 0.57 (0.17; 1.93) .36
 2–3 474 1.43 (0.92; 2.23) .11 2.56 (1.29; 5.10) <.01
 4–5 188 1.37 (0.87; 2.15) .42 1.24 (0.73; 2.08) .42
DM
 No 747 1.23 (0.85; 1.77) .27 1.55 (0.92; 2.59) .10
 Yes 149 1.33 (0.79; 2.22) .28 1.50 (0.80; 2.82) .21